MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Dementia with Lewy bodies (DLB)"

  • 2019 International Congress

    Alpha-synuclein expression and cytokine profile in blood of patients with Lewy body dementias

    T. Usenko, M. Nikolaev, A. Bezroukova, A. Emelyanov, E. Gracheva, I. Milukhina, Y. Belceva, N. Zalutskaya, A. Timofeeva, S. Pchelina (Gatchina, Russian Federation)

    Objective: To examine alpha-synuclein expression in CD45+ and cytokine levels in blood of patients with dementia with Lewy bodies (DLB), Parkinson's disease dementia (PDD). Background:…
  • 2019 International Congress

    New Neuropathological Staging System for Lewy Body Disease

    J. Toledo, L. Walker, J. Trojanowski, I. Mckeith, J. Attems (Houston, TX, USA)

    Objective: Present the validation of the new proposed novel staging system (NSS) for Lewy body disease and compare it against the previously proposed staging systems. Background:…
  • 2018 International Congress

    Polysomnographic data in Dementia with Lewy Bodies: Correlation with clinical features and comparison with other alfa-synucleinopathies

    P. Bugalho, M. Salavisa, J. Marto, C. Borbinha, L. Alves (Lisbon, Portugal)

    Objective: 1) Polysomnography (PSG) assessment of sleep in Dementia with Lewy Bodies (DLB). 2) Correlation between PSG data, fluctuations and hypersomnolence. 3) Comparison of PSG…
  • 2018 International Congress

    Interaction of TDP-43 with IAPP in pancreatic beta cells of patients with sinucleinopathies

    R. Valenti-Azcarate, I. Martinez-Valbuena, C. Arean-Cuns, I. Marcilla-García, L. Alonso-Herrero, M. Carmona-Abellan, G. Marti-Andres, MT. Tuñon-Alvarez, MR. Luquin Piudo (Pamplona, Spain)

    Objective: We have investigated whether deposits of phosphorylated TDP-43 might be present in pancreatic tissue of patients with synucleinopathies. Background: The TAR DNA binding protein…
  • 2018 International Congress

    Effect of Viewpoint and Visual Texture on Object Recognition in Dementia with Lewy Bodies and in Alzheimer’s Disease

    Y. Oishi, K. Suzuki, T. Imamura, T. Shimomura (Niigata, Japan)

    Objective: To examine the effect of viewpoint and visual texture on visual object recognition in mild cognitive impairment (MCI) or dementia due to DLB or…
  • 2018 International Congress

    Motor and non-motor correlates of APOE-ε4 mediated cerebrospinal fluid concentrations of biomarkers of amyloidogenesis and neurodegeneration in dementia with Lewy bodies compared with Alzheimer’s dementia and healthy controls

    F. Oliveira, M. Miraldo, E. Castro-Neto, F. Machado, S. Almeida, S. Matas, P. Bertolucci, M. Naffah-Mazzacoratti (São Paulo, Brazil)

    Objective: To study associations of cerebrospinal fluid biomarkers of amyloidogenesis and neurodegeneration with motor and non-motor aspects of daily experiences in dementia with Lewy bodies…
  • 2018 International Congress

    Papez circuit atrophy in Dementia with Lewy Bodies

    E. Matar, S. Wong, R. Tan, O. Piguet, M. Hornberger, J. Krill, J. Hodges, G. Halliday (Sydney, Australia)

    Objective: In this ex-vivo study, we aimed to assess atrophy in regions and subregions of the Papez Circuit, a network important for memory function, in…
  • 2018 International Congress

    Characterization of color vision impairment in Lewy Body Diseases

    T. Tousi, F. Flanigan, K. Khosravi (Cleveland, OH, USA)

    Objective: We sought to characterize the prevalence of color vision impairment in DLB patients and investigate how color vision impairment in DLB patients was associated…
  • 2018 International Congress

    Comparison of Volumetric MRI measurements between Dementia with Lewy bodies and prodromal Lewy body disease

    B. Tousi, F. Flanigan, k. Khosravi (Cleveland, OH, USA)

    Objective: To compare the volumetric changes between patients at prodromal stage of Lewy body disese and individuals with dementia with Lewy Bodies. Background: Volumetric magnetic…
  • 2018 International Congress

    The shared risk of apolipoprotein E ɛ4-allele on hippocampal volume across the spectrum of Alzheimer’s disease and dementia with Lewy bodies: Evidence from the Sunnybrook Dementia Study

    U. Saeed, S. Mirza, B. MacIntosh, N. Herrmann, J. Keith, J. Ramirez, S. Nestor, J. Knight, W. Swardfager, E. Rogaeva, E. Black, M. Masellis (Toronto, ON, Canada)

    Objective: To identify the association of apolipoprotein E ɛ4-allele (APOE-ε4) with hippocampal volumes across the spectrum of Alzheimer’s disease (AD) and dementia with Lewy bodies…
  • « Previous Page
  • 1
  • …
  • 15
  • 16
  • 17
  • 18
  • 19
  • …
  • 23
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley